147 related articles for article (PubMed ID: 31940324)
1. Efficacy and safety of anti-viral therapy for Hepatitis B virus-associated glomerulonephritis: A meta-analysis.
Fu B; Ji Y; Hu S; Ren T; Bhuva MS; Li G; Yang H
PLoS One; 2020; 15(1):e0227532. PubMed ID: 31940324
[TBL] [Abstract][Full Text] [Related]
2. Treatment of hepatitis B virus-associated glomerulonephritis: a meta-analysis.
Zhang Y; Zhou JH; Yin XL; Wang FY
World J Gastroenterol; 2010 Feb; 16(6):770-7. PubMed ID: 20135728
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis of combined therapy for adult hepatitis B virus-associated glomerulonephritis.
Zheng XY; Wei RB; Tang L; Li P; Zheng XD
World J Gastroenterol; 2012 Feb; 18(8):821-32. PubMed ID: 22371643
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis of the efficacy and safety of nucleotide/nucleoside analog monotherapy for hepatitis B virus-associated glomerulonephritis.
Wang WN; Wu MY; Ma FZ; Sun T; Xu ZG
Clin Nephrol; 2016 Jan; 85(1):21-9. PubMed ID: 26636326
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of anti-viral therapy on hepatitis B virus-associated glomerulonephritis: A systematic review and meta-analysis.
Yi Z; Jie YW; Nan Z
Ann Hepatol; 2011; 10(2):165-73. PubMed ID: 21502678
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis: anti-viral therapy of hepatitis B virus-associated glomerulonephritis.
Fabrizi F; Dixit V; Martin P
Aliment Pharmacol Ther; 2006 Sep; 24(5):781-8. PubMed ID: 16918881
[TBL] [Abstract][Full Text] [Related]
7. Interferon therapy for HCV-associated glomerulonephritis: meta-analysis of controlled trials.
Fabrizi F; Bruchfeld A; Mangano S; Dixit V; Messa P; Martin P
Int J Artif Organs; 2007 Mar; 30(3):212-9. PubMed ID: 17417760
[TBL] [Abstract][Full Text] [Related]
8. Treatment of hepatitis B virus associated glomerulonephritis with recombinant human alpha interferon.
Chung DR; Yang WS; Kim SB; Yu E; Chung YH; Lee Y; Park JS
Am J Nephrol; 1997; 17(2):112-7. PubMed ID: 9096440
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of adefovir dipivoxil combined with a corticosteroid in 38 cases of nephrotic syndrome induced by hepatitis B virus-associated glomerulonephritis.
Li H; Yuan X; Qiu L; Zhou Q; Xiao P
Ren Fail; 2014 Oct; 36(9):1404-6. PubMed ID: 25246340
[TBL] [Abstract][Full Text] [Related]
10. Viral-Associated GN: Hepatitis B and Other Viral Infections.
Kupin WL
Clin J Am Soc Nephrol; 2017 Sep; 12(9):1529-1533. PubMed ID: 27797900
[TBL] [Abstract][Full Text] [Related]
11. [Effect of interferon-alpha treatment in children with hepatitis B e antigen-positive chronic hepatitis B virus infection: a meta-analysis of follow-up for six months to two years].
Lin ZQ; Fang F; Guo ZF; Chen Q
Zhonghua Er Ke Za Zhi; 2007 Aug; 45(8):592-8. PubMed ID: 18021533
[TBL] [Abstract][Full Text] [Related]
12. A Meta-Analysis of Antiviral Therapy for Hepatitis B Virus-Associated Membranous Nephropathy.
Yang Y; Ma YP; Chen DP; Zhuo L; Li WG
PLoS One; 2016; 11(9):e0160437. PubMed ID: 27598699
[TBL] [Abstract][Full Text] [Related]
13. A multi-center open study to determine the effect of lamivudine on HBV DNA clearance and to assess the safety of the regimen in patients with chronic hepatitis B infection.
Mazur W; Król F; Cianciara J; Nazzal K; Gładysz A; Juszczyk J; Bolewska B; Adamek J; Czajka B; Swietek K; Kryczka W; Gonciarz Z
Med Sci Monit; 2002 Apr; 8(4):CR257-62. PubMed ID: 11951067
[TBL] [Abstract][Full Text] [Related]
14. Relationship between hepatitis B virus genotype B and C and response to interferon therapy in HBeAg positive chronic hepatitis B patients: A meta-analysis.
Kong LN; Qin B; Ma Q; Li L; Yao Y
J Gastroenterol Hepatol; 2014; 29(7):1387-95. PubMed ID: 24548048
[TBL] [Abstract][Full Text] [Related]
15. Effect of interferon-alpha-based antiviral therapy on hepatitis C virus-associated glomerulonephritis: a meta-analysis.
Feng B; Eknoyan G; Guo ZS; Jadoul M; Rao HY; Zhang W; Wei L
Nephrol Dial Transplant; 2012 Feb; 27(2):640-6. PubMed ID: 21558431
[TBL] [Abstract][Full Text] [Related]
16. Glomerular Diseases Associated With Hepatitis B and C.
Gupta A; Quigg RJ
Adv Chronic Kidney Dis; 2015 Sep; 22(5):343-51. PubMed ID: 26311595
[TBL] [Abstract][Full Text] [Related]
17. Discontinuation of antiviral prophylaxis increased the risk of hepatitis B virus reactivation in glomerulonephritis patients under immunotherapy: a real-life observation.
Fang J; Li W; Tan M; Chen W; Zhang C; Wang W; Xu Q; Guo X
Int Urol Nephrol; 2018 Sep; 50(9):1653-1660. PubMed ID: 29644524
[TBL] [Abstract][Full Text] [Related]
18. Effects of TACE and preventive antiviral therapy on HBV reactivation and subsequent hepatitis in hepatocellular carcinoma: a meta-analysis.
Zhang SS; Liu JX; Zhu J; Xiao MB; Lu CH; Ni RZ; Qu LS
Jpn J Clin Oncol; 2019 Jul; 49(7):646-655. PubMed ID: 30968933
[TBL] [Abstract][Full Text] [Related]
19. Systematic review with network meta-analysis: Comparative efficacy of oral nucleos(t)ide analogues for the prevention of chemotherapy-induced hepatitis B virus reactivation.
Zhang MY; Zhu GQ; Shi KQ; Zheng JN; Cheng Z; Zou ZL; Huang HH; Chen FY; Zheng MH
Oncotarget; 2016 May; 7(21):30642-58. PubMed ID: 27121321
[TBL] [Abstract][Full Text] [Related]
20. Clinical and pathological characteristics of 5 children with HBV surface antigen (HBsAg)-negative hepatitis B virus-associated glomerulonephritis.
Liu T; Yang S; Yue Z; Kuang Y; Guan W; Sun L
J Clin Virol; 2015 May; 66():1-5. PubMed ID: 25866326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]